Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dundee Team Provides New Insights into Diabetes Treatment

Published: Wednesday, June 06, 2012
Last Updated: Wednesday, June 06, 2012
Bookmark and Share
Scientists to develop more effective ‘second-generation’ medicines in the future.

Researchers from the University of Dundee have made an important discovery about the world’s most commonly prescribed diabetes medicine, which also protects against cancer and cardiovascular disease, opening up the possibility of developing more effective treatments.

The Dundee team, led by Dr Graham Rena of the Department of Cardiovascular and Diabetes Medicine, has furthered understanding of how the type 2 diabetes drug metformin actually works.

They believe this may allow scientists to develop more effective ‘second-generation’ medicines in the future.

Even though the therapeutic action of metformin was first discovered in 1929, the target mediating these effects remained unclear until now.

The Dundee group has discovered that important responses to metformin depend on the drug’s metal-binding properties.

Drugs like metformin have been known to bind to copper since the 19th century, but the role of this in the anti-diabetic effects of the drug was unknown until now.

Dr Rena said, “We have demonstrated that cellular actions of metformin are disrupted by interference with its metal binding properties. This link will illuminate a better understanding of the molecular mechanisms enabling drug action. Further research is now needed to exploit the new tools that we have developed to establish how this unusual property of metformin enables it to be such an effective medicine.”

Metformin is widely used across the globe, and is prioritized over every other treatment option for type 2 diabetes sufferers.

In addition, it is one of only two oral anti-diabetic agents in the World Health Organization’s Model List of Essential Medicines.

Metformin is the best drug for prevention of the cardiovascular complications of diabetes, and has been shown to produce few adverse effects.

This latest study follows work by other investigators in Dundee who were the first to establish that metformin treatment affords type 2 diabetes patients protection against both cancer and cardiovascular disease.

In recent years, it has been shown that metformin displays promise as a treatment for many other conditions and Dr Rena believes this study will further the potential for its use in a number of other situations.

“Metformin is also being investigated for efficacy in a wider range of age-related diseases including cancer, cardiovascular and neurodegenerative disease” he continued.

“Identification of metformin’s target will stimulate the development of second-generation drugs based on metformin, which has been impossible up until now.”

The research, which was funded by Tenovus Scotland, appears in a paper in the current edition of the journal Diabetes.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Launch of DIRECT - An Innovative Medicines Initiative Project for Personalized Medicine in Diabetes
Academia and the pharmaceutical industry working together in the fight against diabetes.
Thursday, February 23, 2012
Dundee Playing Central Role in €12 Million European Union Biomarker Project
The University plays a key role in the research project aiming to find early indicators of cancer types cancer and development of new drugs.
Thursday, May 06, 2010
Scientific News
Newly Identified Biochemical Pathway Could Be Target for Insulin Control
Researchers at Duke Medicine and the University of Alberta are reporting the identification of a new biochemical pathway to control insulin secretion from islet beta cells in the pancreas, establishing a potential target for insulin control.
Dirty,Crusty Meals Fit for (Long-Dormant) Microbes
Researchers apply the latest analytical techniques to further our understanding of desert biocrusts.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
Developing a Breathalyzer-Type Low Blood Sugar Warning Device For Diabetes
A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.
Identifying The 'Dimmer Switch' Of Diabetes
University of Alberta research gives new insight into what causes Type 2 diabetes.
10 to 1: Bugs Win in NASA study
Bugs are winning out, and that's a good thing according to NASA's Human Research Program.
MYC Oncogene Disrupts Cancers Rhythm
Findings inform time-dependent treatment for reducing side effects and increasing effectiveness of cancer medications.
Keeping Gut Bacteria in Balance Could Help Delay Age-related Diseases
A new study suggests that analyzing intestinal bacteria could be a promising way to predict health outcomes as we age.
Genome Mining Effort Discovers 19 New Natural Products in Four Years
Each of these products is a potential new drug. One of them has already been identified as an antibiotic.
New CRISPR-Cas9 Strategy Edits Genes Two Ways
A team of Harvard and MIT researchers have developed a way to perform genome engineering and gene regulation at the same time.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos